From: Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
Variable | Univariate Analysis | ||
---|---|---|---|
HR | 95% CI | P | |
Sex (male vs female) | 0.887 | 0.417–1.887 | .755 |
Age (per year) | 1.011 | 0.943–1.085 | .749 |
Year of decompensation (≤2008 vs > 2008) | 1.238 | 0.563–2.724 | .596 |
Alcohol intake > 50 g/day (yes vs no) | 1.232 | 0.522–2.905 | .634 |
HBsAg (positive vs negative) | 1.210 | 0.366–4.005 | .754 |
Nadir CD4+ (per cell/mm3) | 1.000 | 0.997–1.003 | .920 |
Baseline CD4+ (per cell/mm3) | 0.999 | 0.997–1.001 | .489 |
Esophageal varices (yes vs no) | 0.729 | 0.336–1.582 | .424 |
Liver stiffness (per kPa) | 1.017 | 0.998–1.037 | .078 |
Serum albumin (per g/dL) | 0.482 | 0.298–0.780 | .003 |
FIB-4 (per unit) | 1.095 | 1.024–1.171 | .008 |
Child-Pugh score (per unit) | 1.356 | 1.100–1.671 | .004 |
MELD score (per unit) | 1.111 | 1.022–1.209 | .014 |
LSPS (per unit) | 1.023 | 0.987–1.060 | .220 |
Anti-HCV therapya (no vs yes) | 1.340 | 0.300–5.920 | .695 |